Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1

Nature Communications

Volumn 4, Issue , 2013, Pages

  Ramkumar, Charusheila ^a   Cui, Hang ^a   Kong, Yahui ^a   Jones, Stephen N ^a   Gerstein, Rachel M ^a   Zhang, Hong ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; PROTEIN SMURF2; TRANSCRIPTION FACTOR YY1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

CHEMOTHERAPY; GENE EXPRESSION; PUBLIC HEALTH; RODENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BODY WEIGHT; CANCER SURVIVAL; CARCINOGENICITY; CONTROLLED STUDY; DRIVE; FEMALE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; OVERALL SURVIVAL; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; SPLEEN WEIGHT; TRANSACTIVATION; UBIQUITINATION; UPREGULATION;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMINAL CENTER; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICE; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; YY1 TRANSCRIPTION FACTOR;

EID: 84886876189     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3598     Document Type: Article

References (56)

1. Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429-457 (2012).
2. Pasqualucci, L. et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl Acad. Sci. USA 95, 11816-11821 (1998). (Pubitemid 28460497)
3. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001). (Pubitemid 32691848)
4. Staszewski, O. et al. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells. Mol. Cell 41, 232-242 (2011).
5. Robbiani, D. F. et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135, 1028-1038 (2008).
6. Robbiani, D. F. et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 36, 631-641 (2009).
7. Shen, H. M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752 (1998). (Pubitemid 28283498)
8. Liu, M. et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451, 841-845 (2008). (Pubitemid 351253166)
9. Allen, C. D., Okada, T. & Cyster, J. G. Germinal-center organization and cellular dynamics. Immunity 27, 190-202 (2007). (Pubitemid 47284923)
10. Lenz, G. & Staudt, L. M. Aggressive lymphomas. N. Engl. J. Med. 362, 1417-1429 (2010).
11. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909-3918 (1997).
12. Schneider, C., Pasqualucci, L. & Dalla-Favera, R. Molecular pathogenesis of diffuse large B-cell lymphoma. Semin. Diagn. Pathol. 28, 167-177 (2011).
13. Nogai, H., Dorken, B. & Lenz, G. Pathogenesis of non-Hodgkin's lymphoma. J. Clin. Oncol. 29, 1803-1811 (2011).
14. Coiffier, B. Diffuse large cell lymphoma. Curr. Opin. Oncol. 13, 325-334 (2001). (Pubitemid 32783410)
15. Blank, M. et al. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat. Med. 18, 227-234 (2012).
16. Ramkumar, C. et al. Smurf2 regulates the senescence response and suppresses tumorigenesis in mice. Cancer Res. 72, 2714-2719 (2012).
17. Green, M. R. et al. Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proc. Natl Acad. Sci. USA 108, 2873-2878 (2011).
18. Morse, 3rd H. C. et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100, 246-258 (2002).
19. Dalla-Favera, R., Martinotti, S., Gallo, R. C., Erikson, J. & Croce, C. M. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219, 963-967 (1983). (Pubitemid 13189526)
20. Langdon, W. Y., Harris, A. W., Cory, S. & Adams, J. M. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47, 11-18 (1986). (Pubitemid 17181528)
21. Soucek, L. & Evan, G. I. The ups and downs of Myc biology. Curr. Opin. Genet. Dev. 20, 91-95 (2010).
22. Zeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A. & Dang, C. V. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome. Biol. 4, R69 (2003).
23. Riggs, K. J. et al. Yin-yang 1 activates the c-myc promoter. Mol. Cell Biol. 13, 7487-7495 (1993).
24. Hsu, K. W. et al. The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. Mol. Cell Biol. 28, 4829-4842 (2008).
25. Kavsak, P. et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365-1375 (2000). (Pubitemid 32045929)
26. Lin, X., Liang, M. & Feng, X. H. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factorbeta signaling. J. Biol. Chem. 275, 36818-36822 (2000). (Pubitemid 32002092)
27. Zhang, Y., Chang, C., Gehling, D. J., Hemmati-Brivanlou, A. & Derynck, R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl Acad. Sci. USA 98, 974-979 (2001). (Pubitemid 32121172)
28. Basso, K. et al. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382-390 (2005).
29. Hummel, M. et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 354, 2419-2430 (2006). (Pubitemid 43855045)
30. Lenz, G. et al. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313-2323 (2008).
31. Dave, S. S. et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 351, 2159-2169 (2004). (Pubitemid 39507628)
32. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000). (Pubitemid 30082188)
33. Wright, G. et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 100, 9991-9996 (2003). (Pubitemid 37087056)
34. Sehn, L. H. et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109, 1857-1861 (2007). (Pubitemid 46348180)
35. Castellano, G. et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 8, 1367-1372 (2009).
36. Shi, Y., Lee, J. S. & Galvin, K. M. Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, F49-F66 (1997).
37. Liu, H. et al. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev. 21, 1179-1189 (2007). (Pubitemid 46789876)
38. Castellano, G. et al. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression. Cell Cycle 9, 557-563 (2010).
39. Sakhinia, E. et al. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood 109, 3922-3928 (2007). (Pubitemid 46641745)
40. Lenz, G. et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl Acad. Sci. USA 105, 13520-13525 (2008).
41. Bea, S. et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 106, 3183-3190 (2005). (Pubitemid 41565917)
42. Salaverria, I. et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica 93, 1327-1334 (2008).
43. Scholtysik, R. et al. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica 95, 2047-2055 (2010).
44. Horn, H. et al. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 121, 2253-2263 (2013).
45. Dang, C. V. MYC, microRNAs and glutamine addiction in cancers. Cell Cycle 8, 3243-3245 (2009).
46. Harris, A. W. et al. The E mu-myc transgenic mouse. A model for highincidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167, 353-371 (1988). (Pubitemid 18073641)
47. Evan, G. & Littlewood, T. A matter of life and cell death. Science 281, 1317-1322 (1998). (Pubitemid 28406818)
48. Murphy, D. J. et al. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14, 447-457 (2008).
49. Campaner, S. et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat. Cell Biol. 12, 54-59 sup pp51-14 (2010).
50. Zhang, H. & Cohen, S. N. Smurf2 up-regulation activates telomere-dependent senescence. Genes Dev. 18, 3028-3040 (2004). (Pubitemid 39658172)
51. Zhang, H., Teng, Y., Kong, Y., Kowalski, P. E. & Cohen, S. N. Suppression of human tumor cell proliferation by Smurf2-induced senescence. J. Cell Physiol. 215, 613-620 (2008). (Pubitemid 351632682)
52. Kong, Y., Cui, H. & Zhang, H. Smurf2-mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence. Aging Cell 10, 1038-1046 (2011).
53. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
54. Jolly, C. J., Klix, N. & Neuberger, M. S. Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res. 25, 1913-1919 (1997). (Pubitemid 27303385)
55. Kovalchuk, A. L., Muller, J. R. & Janz, S. Deletional remodeling of c-mycderegulating chromosomal translocations. Oncogene 15, 2369-2377 (1997). (Pubitemid 27496987)
56. Wang, J. H. et al. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. J. Exp. Med. 205, 3079-3090 (2008).